Biostage
Herman has been working in the life sciences industry for over 20 years in various positions including designing and running randomized trial research, optimizing clinical administration of health services, and working as a strategic consultant to the life sciences industry. He joined Trinity over a decade ago and has worked closely with clients to support strategic decision-making across the product lifecycle. Prior to joining Trinity, he worked as a Senior Associate at Boston Healthcare with device and pharmaceutical clients on product entry strategy, business development, and reimbursement strategy. In his work consulting for pharmaceutical/biotech and medical device companies, he has covered several diseases/therapeutic areas including oncology, rare and ultra-rare diseases, cell therapies, cardiovascular, diabetes, hepatitis C, alcohol abuse/dependence, neurological, orthopedic, and renal. He has been published in peer-reviewed publications on various topics including renal disease, suicidal ideation, minority patient recruiting, alcohol use/abuse, and depression/anxiety treatment.
This person is not in the org chart
This person is not in any offices
Biostage
Biostage is a bioengineering company that is developing next-generation esophageal implants. The Company's Cellspan technology combines a proprietary, biocompatible scaffold with a patient's own cells to create an esophageal implant that could potentially be used to treat pediatric esophageal atresia and other conditions that affect the esophagus.